EDTUTC-4 New YorkLog in Sign up

CRVS
Corvus Pharmaceuticals, Inc.
stockNASDAQ

Market OpenOct 5, 2026 11:10:00 AM EDT

10.49USD-3.761%(-0.41)146,188

10.05Bid10.49Ask0.44Spread

CRVS News

Day breaks

04:05 PM EDTCorvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa ·

GlobeNewswire Inc.